Bioactive factors for bone tissue engineering.
暂无分享,去创建一个
[1] M. Marone,et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.
[2] L. Titus,et al. 1998 Volvo Award Winner in Basic Science Studies: Lumbar Spine Fusion by Local Gene Therapy With a cDNA Encoding a Novel Osteoinductive Protein (LMP‐1) , 1998, Spine.
[3] N. Wright,et al. Induction of Bone Formation Using a Recombinant Adenoviral Vector Carrying the Human BMP-2 Gene in a Rabbit Spinal Fusion Model , 1998, Calcified Tissue International.
[4] L. Titus,et al. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2 , 1998 .
[5] G. Finerman,et al. Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[6] M. Mochizuki,et al. Femoral nonunion fracture treated with recombinant human bone morphogenetic protein-2 in a dog. , 1998, The Journal of veterinary medical science.
[7] S. Boden,et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage , 1998 .
[8] T. Gerhart,et al. Healing Bone Using Recombinant Human Bone Morphogenetic Protein 2 and Copolymer , 1998, Clinical orthopaedics and related research.
[9] W. Larrabee,et al. Mandibular Reconstruction With Transforming Growth Factor‐β1 , 1998 .
[10] D. Silcox,et al. Reversing the Inhibitory Effect of Nicotine on Spinal Fusion Using an Osteoinductive Protein Extract , 1998, Spine.
[11] J. Helms,et al. Expression of indian hedgehog, bone morphogenetic protein 6 and gli during skeletal morphogenesis 1 This work was presented in part at the 43rd Annual Meeting of the Orthopaedic Research Society, San Francisco, CA, February 1997. 1 , 1997, Mechanisms of Development.
[12] J. Wozney,et al. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. , 1997, The International journal of oral & maxillofacial implants.
[13] M. Bošković,et al. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. , 1997, The International journal of oral & maxillofacial implants.
[14] J. Wozney,et al. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. , 1997, Journal of spinal disorders.
[15] J. Dawson,et al. Evaluation of bovine‐derived bone protein with a natural coral carrier as a bone‐graft substitute in a canine segmental defect model , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[16] S. Boonen,et al. The prevention or treatment of age‐related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF‐I or rhTGFβ): a perspective , 1997, Journal of internal medicine.
[17] C. Bosch,et al. Recombinant Transforming Growth Factor‐β1 Induces Endochondral Bone in the Baboon and Synergizes with Recombinant Osteogenic Protein‐1 (Bone Morphogenetic Protein‐7) to Initiate Rapid Bone Formation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] R. Yacobi,et al. A Collagenous Cementum‐Derived Attachment Protein Is a Marker for Progenitors of the Mineralized Tissue‐Forming Cell Lineage of the Periodontal Ligament , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] J. Dawson,et al. Bovine-derived bone protein as a bone graft substitute in a canine segmental defect model. , 1997, Journal of orthopaedic trauma.
[20] J. Wozney,et al. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. , 1997, Endocrinology.
[21] A. Linde,et al. Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. An experimental study in rabbits. , 1997, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[22] J M Toth,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Without Decortication of Osseous Elements , 1997, Spine.
[23] K Nakamura,et al. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[24] W. Hutton,et al. In vivo evaluation of a resorbable osteoinductive composite as a graft substitute for lumbar spinal fusion. , 1997, Journal of spinal disorders.
[25] P. Aspenberg,et al. Basic Fibroblast Growth Factor Promotes Bone Ingrowth in Porous Hydroxyapatite , 1996, Clinical orthopaedics and related research.
[26] S. Boden,et al. Video‐Assisted Lateral Intertransverse Process Arthrodesis: Validation of a New Minimally Invasive Lumbar Spinal Fusion Technique in the Rabbit and Nonhuman Primate (Rhesus) Models , 1996, Spine.
[27] M. Bostrom,et al. Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: a comparison using bone chambers in rats. , 1996, Bone.
[28] R. Delamarter,et al. Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.
[29] J. Wozney,et al. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. , 1996, Endocrinology.
[30] B. Hogan,et al. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.
[31] S. Goldstein,et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] W. Hutton,et al. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials--rhBMP-2 and autograft. , 1996, Journal of spinal disorders.
[33] P. Aspenberg,et al. BMP-2 for intramuscular bone induction: effect in squirrel monkeys is dependent on implantation site. , 1996, Acta orthopaedica Scandinavica.
[34] J. Michael Kabo,et al. Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.
[35] W C Hutton,et al. The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part II Study of Dose, Carrier, and Species , 1995, Spine.
[36] D. Silcox,et al. The Effect of Nicotine on Spinal Fusion , 1995, Spine.
[37] W. Hutton,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.
[38] S. Cook,et al. In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.
[39] I. Asahina,et al. Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria , 1993, The Journal of cell biology.
[40] K. Ng,et al. Differential effects of transforming growth factor‐β1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts , 1993, Journal of cellular physiology.
[41] H. Oppermann,et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.
[42] E. E. Johnson,et al. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. , 1992, Clinical orthopaedics and related research.
[43] Arnold I. Caplan,et al. Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[44] V. Rosen,et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro , 1991, The Journal of cell biology.
[45] D. Weisman,et al. Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteoinductive factor. , 1990, Journal of biomedical materials research.
[46] G. Stein,et al. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells , 1990, Journal of cellular physiology.
[47] V. Rosen,et al. Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[48] V. Goldberg,et al. Heterotopic osteogenesis in porous ceramics induced by marrow cells , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[49] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988, Science.
[50] N Muthukumaran,et al. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[52] D. Kingsley,et al. What do BMPs do in mammals? Clues from the mouse short-ear mutation. , 1994, Trends in genetics : TIG.
[53] P. Keto. Percutaneous recanalization and stents of the biliary tree. , 1993, Annales chirurgiae et gynaecologiae.